MDM2 and leukemia: Communication between EGFR and ER can enhance proliferation and reduce the apoptosis of breast cancer cells.27 MDM2 is overexpressed in a variety of malignancies, including sarcomas, leukaemias and solid tumours, which plays a crucial role in the development and progression of tumour.